Immunohistochemistry analysis revealed that LAG-3 is expressed in various cancer tissues, with 90% of NSCLC and 52% of SCLC samples having detectable positive LAG-3 expression (102). This evidence concerns the gene LAG3 and non-small cell lung carcinoma.